Pfizer Shares Hit 52-Week High as Drugmakers Rally
Pfizer shares reached $29.88 Thursday, clearing the previous 52-week peak of $29.21, as drugmakers rose broadly. The FDA approved a Tukysa regimen on Oct. 7.
Pfizer shares reached $29.88 Thursday, clearing the previous 52-week peak of $29.21, as drugmakers rose broadly. The FDA approved a Tukysa regimen on Oct. 7.